Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Improving Prevention of Heart Disease in Latinos (LUCHAR)

This study has been completed.
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
University of Colorado, Denver Identifier:
First received: January 10, 2005
Last updated: September 29, 2015
Last verified: September 2015
The purpose of the study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities. Specifically, it seeks to improve the primary prevention of CVD in Hispanics.

Cardiovascular Diseases
Heart Diseases
Diabetes Mellitus

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Partnership Programs to Reduce Cardiovascular Disparities - Latinos Using Cardio Health Actions to Reduce Risk

Resource links provided by NLM:

Further study details as provided by University of Colorado, Denver:

Enrollment: 179
Study Start Date: September 2004
Study Completion Date: June 2012
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
  Show Detailed Description


Ages Eligible for Study:   21 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
White and Latino patients in a safety net hospital
Eligibility Criteria vary with each study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00101530

United States, Colorado
Denver Health Medical Center
Denver, Colorado, United States, 80204
Sponsors and Collaborators
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI)
Principal Investigator: Edward Havranek, MD Denver Health and Hospital Authority
Principal Investigator: Sheana Bull, PhD University of Colorado Denver/HSC Aurora
  More Information

Responsible Party: University of Colorado, Denver Identifier: NCT00101530     History of Changes
Other Study ID Numbers: 04-0621  U01HL079208  U01HL079160 
Study First Received: January 10, 2005
Last Updated: September 29, 2015
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases processed this record on October 21, 2016